These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 18452561

  • 1. Activation of Toll-like receptor 2 by a novel preparation of cell wall skeleton from Mycobacterium bovis BCG Tokyo (SMP-105) sufficiently enhances immune responses against tumors.
    Murata M.
    Cancer Sci; 2008 Jul; 99(7):1435-40. PubMed ID: 18452561
    [Abstract] [Full Text] [Related]

  • 2. Optimization of cell-wall skeleton derived from Mycobacterium bovis BCG Tokyo 172 (SMP-105) emulsion in delayed-type hypersensitivity and antitumor models.
    Miyauchi M, Murata M, Fukushima A, Sato T, Nakagawa M, Fujii T, Koseki N, Chiba N, Kashiwazaki Y.
    Drug Discov Ther; 2012 Aug; 6(4):218-25. PubMed ID: 23006993
    [Abstract] [Full Text] [Related]

  • 3. Simultaneous blocking of human Toll-like receptors 2 and 4 suppresses myeloid dendritic cell activation induced by Mycobacterium bovis bacillus Calmette-Guérin peptidoglycan.
    Uehori J, Matsumoto M, Tsuji S, Akazawa T, Takeuchi O, Akira S, Kawata T, Azuma I, Toyoshima K, Seya T.
    Infect Immun; 2003 Aug; 71(8):4238-49. PubMed ID: 12874299
    [Abstract] [Full Text] [Related]

  • 4. Isolation and identification of arabinose mycolates of Cell Wall Skeleton (CWS) derived from Mycobacterium bovis BCG Tokyo 172 (SMP-105).
    Uenishi Y, Kusunose N, Yano I, Sunagawa M.
    J Microbiol Methods; 2010 Mar; 80(3):302-5. PubMed ID: 20079769
    [Abstract] [Full Text] [Related]

  • 5. Mycobacterium indicus pranii and Mycobacterium bovis BCG lead to differential macrophage activation in Toll-like receptor-dependent manner.
    Kumar P, Tyagi R, Das G, Bhaskar S.
    Immunology; 2014 Oct; 143(2):258-68. PubMed ID: 24766519
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mycobacterium bovis BCG cell wall-specific differentially expressed genes identified by differential display and cDNA subtraction in human macrophages.
    Begum NA, Ishii K, Kurita-Taniguchi M, Tanabe M, Kobayashi M, Moriwaki Y, Matsumoto M, Fukumori Y, Azuma I, Toyoshima K, Seya T.
    Infect Immun; 2004 Feb; 72(2):937-48. PubMed ID: 14742539
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guérin: involvement of toll-like receptors.
    Tsuji S, Matsumoto M, Takeuchi O, Akira S, Azuma I, Hayashi A, Toyoshima K, Seya T.
    Infect Immun; 2000 Dec; 68(12):6883-90. PubMed ID: 11083809
    [Abstract] [Full Text] [Related]

  • 10. TLR2 and TLR4 serve distinct roles in the host immune response against Mycobacterium bovis BCG.
    Heldwein KA, Liang MD, Andresen TK, Thomas KE, Marty AM, Cuesta N, Vogel SN, Fenton MJ.
    J Leukoc Biol; 2003 Aug; 74(2):277-86. PubMed ID: 12885945
    [Abstract] [Full Text] [Related]

  • 11. Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)- and TLR4-deficient animals.
    Feng CG, Scanga CA, Collazo-Custodio CM, Cheever AW, Hieny S, Caspar P, Sher A.
    J Immunol; 2003 Nov 01; 171(9):4758-64. PubMed ID: 14568952
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Separation and molecular characterization of mycolic acid from the cell wall skeleton of Mycobacterium bovis BCG Tokyo 172 (SMP-105) and BCG substrains by normal-phase high performance liquid chromatography and liquid chromatography/mass spectrometry.
    Uenishi Y, Takii T, Yano I, Sunagawa M.
    J Microbiol Methods; 2009 Jun 01; 77(3):320-2. PubMed ID: 19328829
    [Abstract] [Full Text] [Related]

  • 14. The Combination of MBP and BCG-Induced Dendritic Cell Maturation through TLR2/TLR4 Promotes Th1 Activation In Vitro and Vivo.
    Jiang L, Liu G, Ni W, Zhang N, Jie J, Xie F, Tai G.
    Mediators Inflamm; 2017 Jun 01; 2017():1953680. PubMed ID: 28293065
    [Abstract] [Full Text] [Related]

  • 15. The role of TLR2, TRL3, TRL4, and TRL9 signaling in the pathogenesis of autoimmune disease in a retinal autoimmunity model.
    Fang J, Fang D, Silver PB, Wen F, Li B, Ren X, Lin Q, Caspi RR, Su SB.
    Invest Ophthalmol Vis Sci; 2010 Jun 01; 51(6):3092-9. PubMed ID: 20107166
    [Abstract] [Full Text] [Related]

  • 16. Enhancement of antitumor natural killer cell activation by orally administered Spirulina extract in mice.
    Akao Y, Ebihara T, Masuda H, Saeki Y, Akazawa T, Hazeki K, Hazeki O, Matsumoto M, Seya T.
    Cancer Sci; 2009 Aug 01; 100(8):1494-501. PubMed ID: 19432881
    [Abstract] [Full Text] [Related]

  • 17. TLR2- and 4-independent immunomodulatory effect of high molecular weight components from Ascaris suum.
    Favoretto BC, Silva SR, Jacysyn JF, Câmara NO, Faquim-Mauro EL.
    Mol Immunol; 2014 Mar 01; 58(1):17-26. PubMed ID: 24263181
    [Abstract] [Full Text] [Related]

  • 18. An agonistic anti-Toll-like receptor 4 monoclonal antibody as an effective adjuvant for cancer immunotherapy.
    Tsukamoto H, Kubota K, Shichiku A, Maekawa M, Mano N, Yagita H, Ohta S, Tomioka Y.
    Immunology; 2019 Oct 01; 158(2):136-149. PubMed ID: 31515801
    [Abstract] [Full Text] [Related]

  • 19. MyD88 and TRIF synergistic interaction is required for TH1-cell polarization with a synthetic TLR4 agonist adjuvant.
    Orr MT, Duthie MS, Windish HP, Lucas EA, Guderian JA, Hudson TE, Shaverdian N, O'Donnell J, Desbien AL, Reed SG, Coler RN.
    Eur J Immunol; 2013 Sep 01; 43(9):2398-408. PubMed ID: 23716300
    [Abstract] [Full Text] [Related]

  • 20. Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages.
    Schilling D, Thomas K, Nixdorff K, Vogel SN, Fenton MJ.
    J Immunol; 2002 Nov 15; 169(10):5874-80. PubMed ID: 12421970
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.